1. Home
  2. ESSA vs IPHA Comparison

ESSA vs IPHA Comparison

Compare ESSA & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESSA
  • IPHA
  • Stock Information
  • Founded
  • ESSA 1916
  • IPHA 1999
  • Country
  • ESSA United States
  • IPHA France
  • Employees
  • ESSA N/A
  • IPHA N/A
  • Industry
  • ESSA Banks
  • IPHA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ESSA Finance
  • IPHA Health Care
  • Exchange
  • ESSA Nasdaq
  • IPHA Nasdaq
  • Market Cap
  • ESSA 195.3M
  • IPHA 150.9M
  • IPO Year
  • ESSA N/A
  • IPHA 2019
  • Fundamental
  • Price
  • ESSA $21.43
  • IPHA $1.93
  • Analyst Decision
  • ESSA
  • IPHA Strong Buy
  • Analyst Count
  • ESSA 0
  • IPHA 1
  • Target Price
  • ESSA N/A
  • IPHA $11.50
  • AVG Volume (30 Days)
  • ESSA 43.7K
  • IPHA 50.9K
  • Earning Date
  • ESSA 01-29-2025
  • IPHA 03-20-2025
  • Dividend Yield
  • ESSA 2.86%
  • IPHA N/A
  • EPS Growth
  • ESSA N/A
  • IPHA N/A
  • EPS
  • ESSA 1.74
  • IPHA N/A
  • Revenue
  • ESSA $67,430,000.00
  • IPHA $36,202,722.00
  • Revenue This Year
  • ESSA N/A
  • IPHA N/A
  • Revenue Next Year
  • ESSA N/A
  • IPHA $101.65
  • P/E Ratio
  • ESSA $11.94
  • IPHA N/A
  • Revenue Growth
  • ESSA N/A
  • IPHA N/A
  • 52 Week Low
  • ESSA $15.29
  • IPHA $1.29
  • 52 Week High
  • ESSA $21.62
  • IPHA $3.51
  • Technical
  • Relative Strength Index (RSI)
  • ESSA 65.70
  • IPHA 56.50
  • Support Level
  • ESSA $20.30
  • IPHA $1.72
  • Resistance Level
  • ESSA $21.62
  • IPHA $1.92
  • Average True Range (ATR)
  • ESSA 0.49
  • IPHA 0.10
  • MACD
  • ESSA 0.09
  • IPHA 0.02
  • Stochastic Oscillator
  • ESSA 88.11
  • IPHA 100.00

About ESSA ESSA Bancorp Inc.

ESSA Bancorp Inc is a holding company, engaged in accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in residential first mortgage loans (including construction mortgage loans), commercial real estate loans, home equity loans and lines of credit and commercial and industrial loans. The company offers a variety of deposit accounts, including checking, savings and certificates of deposit. The company also offers asset management and trust services and investment services. The company also offers insurance benefit consulting services through its wholly-owned subsidiary, ESSA Advisory Services, LLC.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: